Pharmaceutical Industry Information Portal

HomeNews

News

Merck KGaA invests about €440 million to expand production in Ireland

Merck KGaA said Monday that it would invest about 440 million euros ($464.8 million) to expand manufacturing in membrane and filtration, as part of...

Bayer intends to discontinue partnership with Atara on CAR-T for $670 million

Atara Biotherapeutics, Inc., a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and...

Cases of monkeypox are being investigated in Europe, the United States, Canada, and Australia

Cases of monkeypox are being investigated in several European countries as well as the US, Canada and Australia, according to health authorities and local...

Viatris and Biocon Biologics launch Abevmy, oncology biosimilar, in Canada

Viatris Inc. and Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced May 19th, that Abevmy® (bevacizumab) is now available in Canada. Abevmy, co-developed...

Amazon and Walmart’s Flipkart in talks to buy a stake in diagnostic chain Metropolis Healthcare

Metropolis Metropolis Healthcare Ltd., a diagnostics chain operating in India and Africa, is looking to raise more than $300 million and bring on board...

Laekna’s next-generation medications raise $61 million

Laekna Therapeutics ("Laekna"), a clinical-stage global biotechnology company dedicated to developing next generation medicines to treat cancer and liver diseases, announced that it has...
spot_img

Expert Articles

spot_img